Our Portfolio

Our companies are developing innovative therapeutics for severe diseases and contitions. We are backing great teams with development programs that make a true difference for patients.

Alentis Therapeutics

AlentisTherapeutics discovers and develops novel mediacations to treat advanced liver diseases, such as liver fibrosis, cirrhosis and liver cancer (hepatocellular carcinoma, HCC).


AM Pharma

AM-Pharma is a clinical stage biopharmaceutical company developing recombinant human Alkaline Phosphatase (recAP) as a potentially life-saving treatment of acute kidney injury and sepsis.


NovaGo Therapeutics

NovaGo Therapeutics is a Swiss start-up dedicated to the development of regenerative therapies for diseases of the central nervous system such as stroke and spinal cord injury.